+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Applications of Nanovesicular Drug Delivery

  • Book

  • July 2022
  • Elsevier Science and Technology
  • ID: 5527424

Applications of Nanovesicular Drug Delivery provides thorough insights and a complete and updated discussion on the preparation, properties and drug delivery applications of various nanovesicles. This volume will discuss target-specific drug application, such as ocular, transdermal, nasal, intravenous and oral delivery. This title is a valuable resource for academics, pharmaceutical scientists, including industrial pharmacists and analytical scientists, health care professionals and regulatory scientists actively involved in pharmaceutical products and process development of tailored-made polysaccharides in drug delivery applications.

Recently, there have been a number of outstanding nanosystems in nanovesicular carrier-forms (such as nanoemulsions, self-nanoemulsifying systems, nanoliposomes, nanotransferosomes, etc.), that have been researched and developed for efficient drug delivery by many formulators, researchers and scientists. However, no previously published books have covered all these drug delivery nanovesicles collectively in a single resource.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Introduction to nanovesicular drug delivery therapeutics
2. Targeting cellular and molecular mechanisms of nanovesicular systems to treat different diseases
3. Nanovesicles for drug co-delivery
4. Theranostic nanovesicles
5. Nanovesicles for oral drug delivery
6. Nanovesicles for ocular drug delivery
7. Nanovesicles for nasal drug delivery
8. Nanovesicles for transdermal drug delivery
9. Nanovesicles for intravenous drug delivery
10. Nanovesicles for target-specific drug delivery
11. Nanovesicles for brain-targeting drug delivery
12. Nanovesicles for tumor-targeting drug delivery
13. Nanovesicles for hepatic-targeting drug delivery
14. Nanovesicles for colon-targeting drug delivery
15. Nanovesicles for delivery of NSAIDs
16. Nanovesicles for delivery of CNS drugs
17. Nanovesicles for delivery of cardiovascular drugs
18. Nanovesicles for delivery of antibiotics
19. Nanovesicles for delivery of antifungal drugs
20. Nanovesicles for delivery of anticancer drugs
21. Nanovesicles for delivery of antiviral drugs
22. Nanovesicles for delivery of protein and peptide drugs
23. Nanovesicles for delivery of siRNA
24. Patented nanovesicles for delivery of drugs
25. Regulatory considerations of nanovesicles for drug delivery uses
26. Clinical trials of nanovesicles for drug delivery uses
27. Challenges and future perspectives of nanovesicles for drug delivery uses

Authors

Amit Kumar Nayak Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.

Dr. Amit Kumar Nayak (MPharm, PhD) is working as a professor, at the Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Odisha, India. He has earned his PhD from IFTM University, Moradabad, Uttar Pradesh, India. He has over 14 years of research experiences in the field of pharmaceutics, especially in the development and characterization of novel biopolymeric and nanostructured drug delivery systems. Till date, he has authored more than 138 research and review publications in various high-impact peer-reviewed journals and 135 book chapters. He has edited/authored 23 international books to his credit. Dr. Nayak has presented his research work at several conferences. He has received University Foundation Day Research Award, 2019 and 2022 by Biju Patnaik University of Technology, Odisha. Dr. Nayak is a life member of the Association of Pharmaceutical Teachers of India (APTI) and a registered pharmacist.

Md Saquib Hasnain Department of Pharmacy, Palamau Institute of Pharmacy, Daltonganj, Jharkhand, India. Prof. (Dr.) Md Saquib Hasnain has over 10 years of research experience in the field of drug delivery and pharmaceutical formulation analyses, especially systematic development and characterization of diverse nanostructured drug delivery systems, controlled release drug delivery systems, bioenhanced drug delivery systems, nanomaterials and nanocomposites employing Quality by Design approaches and many more. Till date he has authored over 70 publications in various high impact peer-reviewed journals, more than 100 book chapters and 16 books to his credit. He is also serving as the reviewer of several prestigious journals. Overall, he has earned a highly impressive publishing and cited record in Google Scholar (h-index: 32). He has also participated and presented his research work at over ten conferences in India, and abroad. He was also a member of scientific societies i.e., Royal Society of Chemistry, Great Britain, International Association of Environmental and Analytical Chemistry, Switzerland and Swiss Chemical Society, Switzerland. Tejraj M. Aminabhavi Director of Research, School of Advanced Sciences, KLE Technological University, Hubballi, Karnataka, India.

Tejraj M. Aminabhavi is the Director of Research at the School of Advanced Sciences, KLE Technological University, Hubballi, India. He works in the area of membrane transport processes, molecular modeling of polymer surfaces, wastewater treatment technologies, drug delivery polymers and sustainable environmental engineering.

Vladimir P. Torchilin University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, USA. Dr Vladimir P. Torchilin is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Mass. He graduated from the Moscow University with MS in Chemistry, and also obtained there his Ph.D. and D.Sc. in Polymer Chemistry, Chemical Kinetics and Catalysis, and Chemistry of Physiologically Active Compounds in 1971 and 1980, respectively. In 1991 Dr. Torchilin joined Massachusetts General Hospital and Harvard Medical School as the Head of Chemistry Program, Center for Imaging and Pharmaceutical Research, and Associate Professor of Radiology. Since 1998 Dr. Torchilin is with Northeastern University. He was there the Chair of the Department of Pharmaceutical Sciences in 1998-2008. His main interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy, cancer immunology, novel imaging agents. He has published more than 500 original papers, more than 250 reviews and book chapters, wrote and edited 13 books, and hold more than 40 patents.